Cargando…
Correction: Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
Autores principales: | Mahumud, Rashidul Alam, Alam, Khorshed, Afroz, Syed, Ormsby, Gail M., Dunn, Jeff, Gow, Jeff |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635459/ https://www.ncbi.nlm.nih.gov/pubmed/37943757 http://dx.doi.org/10.1371/journal.pone.0294379 |
Ejemplares similares
-
Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
por: Mahumud, Rashidul Alam, et al.
Publicado: (2020) -
Correction: The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia
por: Mahumud, Rashidul Alam, et al.
Publicado: (2023) -
The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia
por: Mahumud, Rashidul Alam, et al.
Publicado: (2019) -
Correction: The burden of chronic diseases among Australian cancer patients: Evidence from a longitudinal exploration, 2007–2017
por: Mahumud, Rashidul Alam, et al.
Publicado: (2023) -
The burden of chronic diseases among Australian cancer patients: Evidence from a longitudinal exploration, 2007-2017
por: Mahumud, Rashidul Alam, et al.
Publicado: (2020)